Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
101.14
+2.22 (2.24%)
At close: Apr 24, 2025, 4:00 PM
100.75
-0.39 (-0.39%)
Pre-market: Apr 25, 2025, 7:59 AM EDT
Boston Scientific Revenue
Boston Scientific had revenue of $4.66B in the quarter ending March 31, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to $17.55B, up 19.36% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$17.55B
Revenue Growth
+19.36%
P/S Ratio
8.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
149.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
BSX News
- 16 hours ago - Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints - PRNewsWire
- 17 hours ago - Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results - Benzinga
- 1 day ago - Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition - Benzinga
- 1 day ago - Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire - Investopedia
- 1 day ago - Boston Scientific raises 2025 profit forecast on strong heart device sales - Reuters
- 2 days ago - Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan - PRNewsWire
- 2 days ago - Boston Scientific announces results for first quarter 2025 - PRNewsWire